Oncotarget is a peer-reviewed medical journal that is released weekly. It was started in 2010 and is published by Impact Journals. It only focused on oncology when it was started. The journal features papers in other fields such as cardiology, endocrinology, cell biology, and metabolism. This is because the editors realized that they could help more authors to increase the impact of their research. Its editors-in-chief are Andrei Gudkov and Mikhail Blagosklonny. They work at the Roswell Park Cancer Institute. Gudkov is a professor and the senior vice president for basic research at the Institute. Blagosklonny is a professor of oncology at the Institute. He has written hundreds of articles in peer-reviewed journals. He has acted as the associate editor of various journals including PLOS ONE, Autophagy, and the American Journal of Pathology. Download output styles at Endnote.com.
The journal had an impact rating of 5.0 Last year. It had an average impact factor of 5.4 since it was started seven years ago. The journal has a reach of more than ten thousand cities today. This has made it one of the most popular medical journals. Oncotarget has been ranked among the best journals in the medicine and oncology category since 2011. Oncotarget is currently ranked first among all journals in oncology. It is indexed by Scopus, BIOSIS Previews, and Index Medicus.
Oncotarget’s success is attributed to the high standards set by its editorial board. Its editorial board is made up of distinguished researchers and scientists who have won various awards including the Nobel Prize and the Breakthrough Prize. Oncotarget holds and sponsors medical conferences that are held around the world. They recently sponsored the Gordon Research Conference that was held in Italy. The conference was on the mechanisms of stem cell aging, progression, and cancer initiation.
The journal makes the results of scientific research widely available because it is published online. It has helped to bring researchers from different fields together to work on more papers because it has expanded the number of topics it covers. It allows discoveries to be shared quickly. This has helped to boost the medical research industry. Read more about Oncotarget journal at Bioxbio.